Nataltzumab and alanine aminotransferase increased Patient Reports February 09, 2012

Nataltzumab Side Effects Report #5548339-0
Nataltzumab side effect was reported by a Physician from GREECE on Nov 30, 2007. Female patient, 50 years of age, weighting 149.9 lb, was diagnosed with multiple sclerosis  and was treated with Nataltzumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, autoimmune thyroiditis, bilirubin conjugated increased, blood bilirubin unconjugated increased, gamma-glutamyltransferase increased, headache . Nataltzumab dosage: 300 MG; QM; IV. Patient recovered.